We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

93 hedge funds and large institutions have $193M invested in Rigel Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 31 increasing their positions, 24 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

126% more capital invested

Capital invested by funds: $85.4M → $193M (+$107M)

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

29% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 24

17% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 18

8.47% more ownership

Funds ownership: 59.18% → 67.65% (+8.5%)

2% more funds holding

Funds holding: 91 → 93 (+2)

61% less call options, than puts

Call options by funds: $2.83M | Put options by funds: $7.22M

Holders
93
Holders Change
+2
Holders Change %
+2.2%
% of All Funds
1.34%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
21
Increased
31
Reduced
24
Closed
18
Calls
$2.83M
Puts
$7.22M
Net Calls
-$4.39M
Net Calls Change
-$4.99M

Top Buyers

1
Invesco
Invesco
Georgia
+$12.1M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$5.19M
3
CM
CM Management
Florida
+$3.41M
4
VOYA Investment Management
VOYA Investment Management
Georgia
+$1.44M
5
N
Nuveen
North Carolina
+$1.35M

Top Sellers

1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.51M
2
SCM
Soleus Capital Management
Connecticut
-$1.28M
3
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$1.12M
4
AC
Armistice Capital
New York
-$1.03M
5
Jane Street
Jane Street
New York
-$944K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$25.3M +$571K +48,544 +3%
AC
2
Armistice Capital
New York
$24.9M -$1.03M -88,000 -5%
Morgan Stanley
3
Morgan Stanley
New York
$23.7M +$454K +38,643 +3%
Invesco
4
Invesco
Georgia
$17M +$12.1M +1,032,755 +5,552%
Vanguard Group
5
Vanguard Group
Pennsylvania
$15.9M +$278K +23,662 +2%
SCM
6
Soleus Capital Management
Connecticut
$15.1M -$1.28M -108,909 -10%
Assenagon Asset Management
7
Assenagon Asset Management
Luxembourg
$7.15M +$5.19M +441,765 New
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
$6.82M -$1.51M -128,358 -23%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$6.47M +$104K +8,881 +2%
State Street
10
State Street
Massachusetts
$5.95M +$30K +2,552 +0.7%
SCM
11
Stonepine Capital Management
Oregon
$5M +$48.2K +4,100 +1%
CM
12
CM Management
Florida
$4.69M +$3.41M +290,000 New
VOYA Investment Management
13
VOYA Investment Management
Georgia
$3.9M +$1.44M +122,090 +103%
Jacobs Levy Equity Management
14
Jacobs Levy Equity Management
New Jersey
$2.87M -$716K -60,913 -26%
Northern Trust
15
Northern Trust
Illinois
$2.33M +$49.2K +4,182 +3%
Renaissance Technologies
16
Renaissance Technologies
New York
$2.3M -$35.3K -3,000 -2%
UOC
17
UBS O'Connor
Illinois
$1.89M +$288K +24,467 +26%
N
18
Nuveen
North Carolina
$1.86M +$1.35M +115,163 New
Connor, Clark & Lunn Investment Management (CC&L)
19
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.59M +$264K +22,443 +30%
KCM
20
Kennedy Capital Management
Missouri
$1.53M +$54.3K +4,615 +5%
Charles Schwab
21
Charles Schwab
California
$1.25M -$24 -2 -0%
Los Angeles Capital Management
22
Los Angeles Capital Management
California
$1.21M +$224K +19,094 +34%
BCM
23
Bridgeway Capital Management
Texas
$1.04M – – –
Fidelity Investments
24
Fidelity Investments
Massachusetts
$778K +$308K +26,184 +119%
Goldman Sachs
25
Goldman Sachs
New York
$746K +$542K +46,113 New
1
2 3 4 5

RIGL Hedge Fund Activity: Q3 2024 in Review

93 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q3 2024, worth a combined $193M — up 126% from $85.4M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new RIGL positions and 18 closed out — a net gain of 3 holders — while 31 added to existing stakes and 24 trimmed.

The largest buyer was Invesco, adding an estimated $12.1M. The largest seller was Acadian Asset Management, cutting an estimated $1.51M.

  • 93 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q3 2024, up from 91 in Q2 2024.
  • Funds reported $193M of Rigel Pharmaceuticals stock for Q3 2024, up 126% quarter-over-quarter.
  • 21 funds opened new Rigel Pharmaceuticals positions in Q3 2024 and 18 closed out, a net change of +3 holders.
  • The largest Rigel Pharmaceuticals buyer in Q3 2024 was Invesco, an estimated $12.1M added.
  • The largest Rigel Pharmaceuticals seller in Q3 2024 was Acadian Asset Management, an estimated $1.51M sold.

Based on aggregated 13F filings for Q3 2024.